GURUFOCUS.COM » STOCK LIST » Industrials » Construction » Exponent Inc (NAS:EXPO) » Definitions » Cash And Cash Equivalents

Exponent (Exponent) Cash And Cash Equivalents

: $187.2 Mil (As of Dec. 2023)
View and export this data going back to 1985. Start your Free Trial

Exponent's quarterly cash and cash equivalents declined from Jun. 2023 ($148.17 Mil) to Sep. 2023 ($137.10 Mil) but then increased from Sep. 2023 ($137.10 Mil) to Dec. 2023 ($187.15 Mil).

Exponent's annual cash and cash equivalents declined from Dec. 2021 ($297.69 Mil) to Dec. 2022 ($161.46 Mil) but then increased from Dec. 2022 ($161.46 Mil) to Dec. 2023 ($187.15 Mil).


Exponent Cash And Cash Equivalents Historical Data

The historical data trend for Exponent's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exponent Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash And Cash Equivalents
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 176.44 197.53 297.69 161.46 187.15

Exponent Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash And Cash Equivalents Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 161.46 125.65 148.17 137.10 187.15

Exponent Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


Exponent  (NAS:EXPO) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


Exponent Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Exponent's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


Exponent (Exponent) Business Description

Industry
Traded in Other Exchanges
Address
149 Commonwealth Drive, Menlo Park, CA, USA, 94025
Exponent Inc provides engineering and scientific consulting services on a project-by-project basis. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which accounts for the majority of revenue, provides servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.
Executives
Reitman Maureen T. F. officer: Group Vice President 149 COMMONWEALTH DRIVE, MENLO PARK CA 94025
Bradley A James officer: Group Vice President 149 COMMONWEALTH DRIVE, MENLO PARK CA 94025
Steven J Murray officer: Group Vice President 149 COMMONWEALTH DRIVE, MENLO PARK CA 94025
Richard Reiss officer: Group Vice President 149 COMMONWEALTH DRIVE, MENLO PARK CA 94025
Joseph Rakow officer: Group Vice President 149 COMMONWEATH DRIVE, MENLO PARK CA 94025
Eric Guyer officer: Group Vice Presient 149 COMMONWEALTH DRIVE, MENLO PARK CA 94025
Harri Kytomaa officer: Group Vice President 149 COMMONWEALTH DRIVE, MENLO PARK CA 94025
Carol Lindstrom director 5994 SILVERADO TRAIL, NAPA CA 94558
Sally Shepard officer: VP, Human Resources 149 COMMONWEALTH DRIVE, MENLO PARK CA 94025
George H. Brown director 149 COMMONWEALTH DRIVE, MENLO PARK CA 94025
Paul R Johnston officer: Chief Operating Officer EXPONENT INC, 149 COMMONWEALTH DRIVE, MENLO PARK CA 94025
John Joseph Doyle officer: Group Vice President 149 COMMONWEALTH DRIVE, MENLO PARK CA 94025
Schlenker Richard L Jr officer: Chief Financial Officer EPONENT INC, 149 COMMONWEALTH DRIVE, MENLO PARK CA 94025
John Pye officer: Group Vice President 149 COMMONWEALTH DRIVE, MENLO PARK CA 94025
Debra Zumwalt director 149 COMMONWEALTH DRIVE, MENLO PARK CA 94025